shutterstock_1099396679.jpg

Enabling Rapid Point-of-Care and At-Home Diagnostics

We combine multiplexing capabilities (simultaneous testing for several proteins and nucleic acids), with central lab-like precision, in one affordable and quick test, easily performed on a finger prick sample, at the point-of-need: transportation hubs, local pharmacies, schools, and workplaces, or even ones’ home.  

Point-of-Care Diagnostics

Point-of-Care (POC) testing has been the ‘Holy Grail’ of medical diagnostics for decades. Despite the pressing need and vast resources devoted to the field, the goal has not yet been realized and at times seemed unattainable. 

Our disruptive Q-SENS platform meets all the necessary conditions to become a scalable POC solution, including: 

Performance

Sensitivity and specificity equal to or better than a central lab

Small Sample

A finger-prick or small volume of other bodily fluids

Quick Results

Quantitative kinetic detection in under 10 minutes

Simple

Easy to operate and requires minimal training

Multiplexing

Testing several biomarkers simultaneously in 32 sesnsing-wells

Low Cost

Highly affordable instrument and consumables

Learn more about our unique solution here.

Use Cases

We are currently focused on two highly valuable testing solutions:

The first, monitoring and digitalizing individuals' immune system profiles to allow for early detection and timely and personalized intervention to preempt a range of non-communicable chronic diseases of aging. These include cardiovascular diseases, neurodegenerative disorders, pulmonary illness, various forms of cancer, diabetes, and more, that together account for an estimated 71% of human deaths worldwide. 

The second, scaling an operational response apparatus to pathogenic outbreaks such as the COVID-19 pandemic, offering three rapid point-of-care testing solutions: (1) pathogen structural protein detection in relevant bodily fluids; (2) highly accurate serological antibody testing; and (3) risk stratification of individuals to anticipate disease severity. 

Our Q-SENS platform has demonstrated exceptional performance on ~50 different assays (immunoassays and molecular), spanning a range of applications in fields of medical diagnostics, immunology, veterinary, food safety, dietary, and more. 

We are happy to discuss new use cases for our technology on the basis of newly generated knowledge and lab-developed tests (LDTs), and widen the scope of our technology's applications. Contact us to explore collaboration! 

Target Use Cases

Focusing on the Most Urgent Needs

COVID-19 Infection Risk Index
Cytokine Profiling to Anticipate Disease Severity
SARS-CoV-2 DIAGNOSTICS
Multiplexed Detection of SARS-CoV-2 Structural Proteins
COVID-19 SEROLOGICAL ANTIBODY TESTING
Multiplexed Antibody (IgM, IgG1 & IgG3) Testing
Inflammation Monitoring
Listening to our Immune System
Show More
  • YouTube
  • LinkedIn